Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Ultragenyx Pharmaceutical Inc. 401(K) Plan And Trust is a benefit plan reported by Ultragenyx Pharmaceutical Inc. under EIN 27-2546083 and plan number 001. The latest loaded filing year is 2023. The filing reports 1,429 participants and $166,368,074 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $166,368,074
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $166,368,074
- Net assets (BOY)
- $117,338,679
Income & contributions
- Employer contributions
- $9,728,539
- Participant contributions
- $21,998,289
- Total contributions
- $34,893,323
- Total income / additions
- $61,169,168
Expenses & distributions
- Benefits paid
- $12,052,402
- Administrative expenses
- $74,914
- Total expenses
- $12,139,773
- Net increase / (decrease)
- $49,029,395